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Muscle atrophy derived from excessive proteolysis is a hallmark of numerous disease conditions. Accordingly, the
negative consequences of skeletal muscle protein breakdown often overshadow the critical nature of proteolytic
systems in maintaining normal cellular function. Here, we discuss the major cellular proteolysis machinery—the
ubiquitin/proteosome system, the autophagy/lysosomal system, and caspase-mediated protein cleavage—and the
critical role of these protein machines in establishing and preserving muscle health. We examine how ordered
degradation modifies (1) the spatiotemporal expression of myogenic regulatory factors during myoblast
differentiation, (2) membrane fusion during myotube formation, (3) sarcomere remodeling and muscle growth
following physical stress, and (4) energy homeostasis during nutrient deprivation. Finally, we review the origin and
etiology of a number of myopathies and how these devastating conditions arise from inborn errors in proteolysis.
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Maintaining protein homeostasis (proteostasis) is a critical
factor in preventing cellular dysfunction and the propaga-
tion of many disease states. Proteostasis requires both pro-
tein synthesis and degradation, although the latter is more
often associated with pathological states than with normal
cellular functioning. The negative connotation of protein
degradation is particularly evident for skeletal muscle,
where excessive protein destruction is the principle mech-
anism behind muscle atrophy and weakness. This view is
propagated by the fact that activation of proteolysis is a
feature of a number of pathologies, including cancer, sep-
sis, uremia, acquired immune deficiency syndrome, and
diabetes mellitus (reviewed in [72]). While the concern
regarding the aberrant activation of proteolysis is justified
in these disease states, a strictly negative association
ignores the fact that the long-term viability and mainten-
ance of any organ system will require regular protein
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tems in skeletal muscle is especially acute when one
considers the unique requirements for this tissue. Skel-
etal muscles are the force-generating structures of the
body and are constantly challenged by mechanical, heat,
and oxidative stress. These events increase protein dam-
age and require efficient protein turnover to maintain
optimal functioning. Furthermore, skeletal muscle repair
and regeneration is dependent upon the differentiation
of satellite cell-derived myoblasts [13], which requires
extensive remodeling and the spatiotemporal expression
of myogenic factors. This, of course, requires the temporal
destruction and synthesis of the appropriate proteins.
These examples illustrate the necessity of proteolysis in
skeletal muscle, and this review will focus on the critical
nature of proteolytic systems—namely proteasome-,
autophagy-, and caspase-mediated proteolysis—to sustain
skeletal muscle health and development.Proteasome-mediated proteolysis
Perhaps the most well-known cellular proteolytic system
is the ubiquitin/proteasome pathway (UPP), which is
responsible for degrading the majority of cellular pro-
teins [93]. This is a system whereby proteins meant for
destruction are enzymatically tagged with the polypep-
tide ubiquitin via E3 ubiquitin ligases. These taggeddistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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a large barrel protein complex that consists of a 20S core
particle associated with two 19S regulatory subunits.
The latter subunits recognize and bind the ubiquitinated
proteins and begin their adenosine triphosphate (ATP)-
dependent destruction within the catalytic core [119]. In
the skeletal muscle, protein degradation via the prote-
asome is often associated with muscle atrophy. Indeed,
muscle wasting is characterized by increased proteolysis
via the UPP, increased ubiquitin conjugation to muscle
proteins, and an up-regulation of ubiquitin-protein li-
gases (reviewed by [58]). However, this clear role in
muscle atrophy minimizes the necessity of the UPP in
maintaining normal muscle functioning. The following
sections highlight the essential roles of the UPP in the
skeletal muscle.
Proteasome and muscle cell differentiation
Myogenesis is a complex process that is dependent on
the spatiotemporal expression of a variety of myogenic
regulatory factors. As myoblast differentiation proceeds,
there is a need for timely synthesis and degradation of
the appropriate myogenic proteins, which suggests a sig-
nificant role for adaptive proteolysis in the myogenic
process. Indeed, early studies indicated that proteasome
inhibition decreased myoblast fusion and differentiation
[36, 75] and prevented the degradation of key myogenicFig. 1 The role of the UPP in skeletal muscle cell differentiation. The fidelit
expression of particular myogenic proteins. Indeed, UPP involvement in sat
Pax7, which maintain satellite cells in their stem cell niche. Further, the 26S
factor, MyoD, through the removal of an endogenous MyoD inhibitor, Id. T
degradation of MyoD and its binding partner E2A (E), as well as Myf5, myoproteins, such as MyoD. MyoD degradation via the UPP
was further confirmed by a series of studies [1, 48, 104,
105] and was accompanied by the revelation that many
of the other proteins critical to the progression of the
myogenic program were degraded in a similar manner
(Fig. 1). This extends to the myogenic regulatory factors
Myf5 [61], myogenin [47], Id1 (negative regulator of
MyoD; [105]), E2A proteins [106], and filamin B [8].
Interestingly, both Pax3 and Pax7 are also subject to
ubiquitin-mediated degradation, implying that the acqui-
sition of differentiation competence requires proteolytic
cleavage [10, 11]. In addition, recent evidence has sug-
gested that the immunoproteasome—so called due to
the interferon-γ-induced expression of three alternative
proteasome β subunits—also plays a role in myogenesis,
with its suppression leading to decreased myoblast dif-
ferentiation [16].
The necessity of proper proteasome functioning dur-
ing myoblast differentiation may extend beyond the ef-
fects on the spatiotemporal expression of transcription
factors. For instance, myogenesis is a period of intense
restructuring that relies on increased mitochondrial en-
ergy production. As a by-product, differentiating myo-
blasts produce increased levels of reactive oxygen
species (ROS) and an elevated level of oxidized proteins,
which must be degraded [67]. Without proper prote-
asome functioning, the accumulated oxidized proteinsy of muscle cell differentiation is dependent upon the spatiotemporal
ellite cell differentiation begins with its role in the removal of Pax3 and
proteasome appears critical for the early activation of a key myogenic
he continuation of the myogenic program relies on UPP-dependent
genin, and filamin B (Fil B) during later stages of differentiation
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initiate apoptosis [27]. Taken together, myogenesis ap-
pears to integrate proteasome-mediated proteolysis to
achieve effective myoblast differentiation.
Proteasome and muscle growth
Recently, researchers have demonstrated that the
muscle-specific knockout of an essential 26S proteasome
protein, Rpt3 (also known as Psmc4), leads to a signifi-
cant deficit in muscle growth and force generation in
mice [52]. This sentiment is echoed in earlier publica-
tions on proteasome function in Drosophila muscle,
where the conditional expression of a mutant prote-
asome β subunit (within the 20S core particle) led to the
deterioration of muscle architecture [40].
The apparent role of the UPP in muscle growth and in-
tegrity suggests that proteasome-mediated protein degrad-
ation may be important during exercise. Indeed, acute
bouts of resistance exercise have been shown to increase
both protein synthesis and breakdown in skeletal muscle
[92]. Moreover, numerous studies have indicated that the
expression of two muscle-specific ubiquitin ligase genes,
muscle really interesting novel gene (RING) finger-1
(MuRF1) and muscle atrophy F-box (MAFbx; also called
atrogin-1), increased following acute resistance exercise
(reviewed by [78]), suggesting increased proteasome-
mediated proteolysis post-exercise. Similarly, both acute
and chronic bouts of endurance exercise appear to in-
crease proteasome-mediated proteolysis. In the former
case, a single bout of endurance running led to increased
expression of MuRF1 and atrogin-1 immediately after the
run (0–4 h post-exercise), suggesting increased UPP flux
[64, 85]. Interestingly, chronic endurance exercise (i.e., 8-
week running regimen) in mice also elicited a sustained
increase in MuRF1 expression and proteasome activity
[18]. The reason for the sustained activation of the UPP as
compared to untrained animals can only be speculated;
however, it may stem from the increased oxidative cap-
acity (and therefore ROS-derived protein damage) that is
a characteristic of trained skeletal muscle. More recently,
Baehr et al. [7] found that chronic loading of mice skeletal
muscle using the functional overload model led to skeletal
muscle hypertrophy that was characterized by increased
protein synthesis and degradation via the UPP. However,
in contrast to the study by Cunha et al. [18], this increased
proteasome activity was independent of MuRF1 (and
MAFbx) expression. Interestingly, recent studies have
indicated that several other ubiquitin ligases may have
important roles in determining skeletal muscle-associated
phenotypes, including TRIM32 [54, 80], MUSA1 [98],
MG53 [121], and Nedd4-1 [79]. In any case, the surge in
protein breakdown following resistance and endurance
exercise has been hypothesized to be adaptive, as it rids
muscles of damaged proteins and facilitates myofilamentrestructuring and muscle growth (Fig. 2). Collectively,
these studies offer an alternative function for the prote-
asome, for what otherwise has been largely considered to
be a conveyor of muscle wasting and pathology.
Autophagy/lysosome-mediated proteolysis
Autophagy is one of the major protein degradative path-
ways within virtually all cells of the body. It involves the
sequestration of dysfunctional proteins or organelles in
membrane bound vesicles (termed autophagosomes) and
the subsequent fusion of these vesicles with lysosomes,
where the encapsulated cytoplasmic material is degraded
and essential biomolecules recycled [59]. Autophagy was
originally identified as a form of programmed cell death
and is often thought of as one of the principle mecha-
nisms that spur muscle wasting [96]. Nevertheless, au-
tophagy is important in maintaining healthy muscle and
is critical in muscle adaptation to sublethal cellular
stress. The following sections will explore the various
roles of autophagy in maintaining skeletal muscle func-
tioning, as well as the role of this process in skeletal
muscle relevant stress responses.
Autophagy and muscle mass maintenance
Several studies over the past decade have indicated
that excessive autophagy aggravates muscle wasting
and contributes to muscle weakness [25, 68, 111, 118,
122]. Indeed, autophagosome accumulation has been ob-
served in nearly all myopathies [66]. However, recent evi-
dence has indicated that basal autophagy is necessary to
maintain muscle mass and prevent atrophy. Much of this
evidence is derived from studies of autophagy-deficient
mice, where critical autophagy-related genes have been
knocked out (i.e., Atg5 and Atg7). In the latter case,
muscle-specific knockout of Atg7 causes muscle cells to
adopt myopathic characteristics such as misalignment of
the Z-line, abnormal enlargement of mitochondria, dis-
tended sarcoplasmic reticulum (SR), and the formation of
aberrant membranous structures [70]. Moreover, Atg7−/−
mice showed a 20–40 % age-dependent reduction in
muscle fiber cross-sectional area with a corresponding
decrease in force generation. A similar decrease in muscle
cross-sectional area was observed in Atg5−/− mice; however,
this decrease did not appear to translate into decreased
muscle performance [90]. Moreover, Atg5−/− mice dis-
played further similarities to the Atg7 knockout mice in-
cluding the accumulation of membranous structures and
the formation of protein aggregates. Taken together, these
initial studies highlight the necessity for basal autophagy in
muscle mass maintenance.
One of the key factors in muscle mass maintenance is
the regenerative capacity of the muscle satellite cells.
Recent evidence has now placed autophagy at the heart
of muscle regeneration, with this process being
Fig. 2 The role of the UPP in skeletal muscle growth. Exercise-induced protein damage via increased ROS/mechanical and heat stress necessitates
an increase in proteasome-mediated proteolysis to rid the cells of non-functional myofibrillar proteins. This is typically dependent on a prerequisite
increase in key muscle-specific ubiquitin ligases, MuRF1 and atrogin-1 (MAFbx), which ubiquitinate and target damaged proteins for degradation by
the 26S proteasome. Efficient removal of damaged proteins is critical to skeletal muscle growth and remodeling following exercise
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from taking on a senescent state. Stem cell senescence
appears to be the main culprit limiting muscle regener-
ation in aging mammalian muscle, which thereby sug-
gests that efficient autophagic signaling is necessary in
preventing sarcopenia [35]. Moreover, muscle stem cell
activation also appears reliant on autophagy, as it is
thought to provide the necessary nutrients to meet the
bioenergetics demands of satellite cells transitioning
from quiescence to activation [109].
In addition to the basal requirement of autophagic flux
to maintain muscle mass and muscle regeneration cap-
acity, there is a growing evidence for an essential role
for autophagy in exercise-induced muscle growth. Most
recently, Redd1−/− (regulated in development and DNA
damage responses 1; an inhibitor of mTORC1) mice dis-
play decreased autophagic flux and a significant decline
in exercise capacity [87]. Indeed, the mechanical stress
and the simultaneous production of ROS during physical
exercise [75] increase the necessity for autophagic
removal of damaged cellular components. Moreover,
autophagy may be necessary during exercise-induced
energy stress to provide muscle cells with an alternative
energy source.
Some of the more convincing evidence for the import-
ance of autophagy during physical exercise stem fromstudies of ultra-endurance runners. For instance, a re-
cent study indicated that these runners display a 50 %
decrease in FoxO3 phosphorylation (consistent with its
activation and translocation into the nucleus), a fivefold
increase in the phosphatidylethanolamine-conjugated
microtubule-associated protein 1A/1B-light chain 3
(LC3-II) expression (indicative of increased autophagy),
and a significant increase in Atg5-Atg12 complex forma-
tion (important for autophagosome formation) [45]. A
study by the same group also indicated that a bout of
ultra-endurance running increased skeletal muscle
expression of key autophagy genes such as Atg4b, Atg12,
Gabarap1, LC3, Bnip3, and Bnip3l [46]. It is likely that
these studies on endurance runners represent an
extreme example of skeletal muscle stress, which
requires autophagy to meet energetic demands and allow
for the removal of dysfunctional proteins/organelles that
will inevitably accumulate with extreme contractile
demands.
In juxtaposition to the studies on ultra-endurance run-
ning, the effects of acute and chronic exercise on the
autophagic response in skeletal muscle cells appear to be
inconclusive. With respect to acute bouts of exercise, one
investigation demonstrated that murine skeletal muscle
autophagosome formation increased after ~30 min of
treadmill running. Furthermore, the transgenic mice used
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induced autophagy through the release of beclin-1 from
the B cell lymphoma 2 (BCL2)-beclin-1 complex (Fig. 3),
display a marked reduction in endurance during acute
treadmill running [41]. Thus, this study indicates not only
that autophagy is induced during short-term exercise but
that the lack of autophagic flux hinders muscle perform-
ance. Grumati and colleagues [39] also found that a 60-
min bout of treadmill running was capable of increasing
autophagic flux in murine skeletal muscles, as evidenced
by increased LC3 lipidation (i.e., conversion of LC3-I to
LC3-II via phosphatidylethanolamine conjugation). Most
recently, an acute bout of exercise (60–90 min in dur-
ation) caused a significant increase in autophagic signaling
in both mouse and human skeletal muscle [74, 109]. OneFig. 3 Exercise- and starvation-induced autophagy pathways and their ben
signaling through insulin/growth factor receptors, which decreases Akt act
FoxO3 is then able to translocate into the nucleus and initiate the transcrip
mTORC1 (preventing its action on ULK1, a key autophagy-related kinase
clearance of encapsulated material. Moreover, the lack of intake of esse
autophagy induction. Taken together, these processes recycle nutrients
While starvation-induced autophagy is undoubtedly a part of muscle bi
through its phosphorylation-dependent release from the BCL2-beclin-1
efficient clearance of damaged organelles and proteins that arise frompotential aspect of increased autophagy following acute
exercise appears to be in mediating mitochondrial turn-
over (termed mitophagy), which was recently shown to be
coordinated, in part, by the transcriptional coactivator
peroxisome proliferator-activated receptor-γ coactivator-
1α (PGC-1α) [116]. In contrast to these studies, Kim et al.
[50] demonstrated that 50 min of treadmill running
decreased the expression of autophagy-related genes (i.e.,
LC3, beclin-1, and Atg7), a few hours post-exercise. It is
important to note that the exercise regimens between
these studies were not identical and varied in aspects such
as speed, treadmill inclination, and time. These are likely
significant factors given the recent research by Schwalm
et al. [99] that indicates that exercise intensity may be the
crucial factor in determining the induction of autophagy.eficial role in muscle stress adaptation. Nutrient deprivation decreases
ivation and allows for the AMPK-dependent phosphorylation of FoxO3.
tion of autophagy-related genes. Activated AMPK also phosphorylates
) and ULK1 to allow for efficient autophagosome formation and
ntial amino acids further prevents mTORC1 activation and promotes
for muscle cells and the body as a whole during lean periods.
ochemistry during exercise, physical activity also activates beclin-1
complex. Beclin-1 is critical to autophagosome formation and the
physical stress
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tion may stem from intrinsic differences in muscle glycogen
reserves and pre-exercise energy status (i.e., AMP to ATP
ratio and the corresponding activation state of AMP-
dependent protein kinase (AMPK)). Indeed, it is reasonable
to assume that a threshold may exist during aerobic exer-
cise where muscle cells engage in autophagy-mediated
breakdown of damaged organelles/proteins to ensure nor-
mal functioning and energy homeostasis.
Similar to the above situation, skeletal muscle autoph-
agic flux following chronic exercise appears to be quite
variable. For instance, analysis of the tibialis anterior
(TA) muscle in mice that were allowed to spontaneously
exercise on a running wheel for 3 months did not show
any evidence of LC3 lipidation [39]. Conversely, investi-
gation of the plantaris muscle in mice subjected to
4 weeks of voluntary running displayed increased LC3
lipidation, decreased p62 protein content (indicating
greater autophagic flux), and increased expression of a
number of autophagy-related proteins (i.e., Atg6, LC3,
and Bnip3) [62]. A recent study confirmed these findings
with basal autophagy in mice plantaris muscle being in-
duced after a 20-week period of voluntary exercise [108].
One major difference between these two studies and the
previous study on the TA muscle is the difference in
muscle types analyzed. Plantaris is composed of mixed
muscle fiber types (glycolytic/oxidative) while the TA is
a mainly composed of glycolytic (type II) fibers [3, 110].
Muscles with mixed muscle fiber types often become
more oxidative with chronic aerobic exercise [108], and
thus, an induction of autophagy may be necessary as an
adaptive mechanism to deal with increased oxidative
stress and mitochondrial turnover. Recently, a study of
the rectus femoris muscle (consisting of mixed fiber
types) following 2 months of exercise training displayed
increased LC3 expression, decreased p62 expression, and
an overall increase in autophagic flux [44]. Similarly,
analysis of rat soleus muscle (composed of mainly oxida-
tive muscle fibers) after chronic exercise (1 h/day,
6 days/week, for 8 weeks) showed increases in a variety
of autophagy-related genes such as Atg7, beclin-1, and
LC3 [28]. These rats also displayed mitochondrial dys-
function and the induction of an oxidative stress re-
sponse, which may explain the increases in autophagy
markers.
Autophagy and nutrient stress response
Nutrient deprivation is one of the most potent activators
of autophagy, and while this generally promotes muscle
wasting, the process appears necessary in times of en-
ergy stress to supply the body with catabolic substrates
to allow continued functioning [91]. Indeed, in vivo ana-
lysis has indicated that there is a significant increase in
autophagosome formation in skeletal muscle following a24-h period of starvation in mice [73]. Interestingly,
autophagosome formation differed between muscle fiber
types, with fast-twitch muscle fibers showing a signifi-
cantly greater autophagic response as compared to slow-
twitch muscle fibers [73]. Previous studies on the overall
protein degradation have indicated that slow-twitch
muscle fibers are more resilient than fast-twitch fibers
during starvation [31, 60], which may be adaptive given
the importance of slow-twitch fibers in maintaining
posture.
In recent years, significant strides have been made in de-
termining the mechanism by which nutrient deprivation
triggers skeletal muscle autophagy (Fig. 3). Early evidence
indicated that starvation-induced autophagy was mediated
via the Akt/FoxO3 axis [68, 122]. Specifically, the lack of
growth factor- and insulin-dependent signaling during nu-
trient deprivation suppresses Akt activation and subse-
quent FoxO3 phosphorylation (at Akt specific sites). This
then allows for the nuclear translocation of FoxO3 and
the transcriptional initiation of autophagy-related genes,
such as those essential for autophagosome formation
(Atg12l, Atg4b, Gabarapl1, and LC3) and the regulation of
autophagy (Bnip3, Bnip3L, and Vps34) [68, 122]. Further
research indicated that transcriptional activation of FoxO3
was promoted by AMP-dependent protein kinase
(AMPK)-dependent phosphorylation. AMPK also appears
to bind and regulate Unc-51 like autophagy activating kin-
ase 1 (ULK1), which is important in the induction of
autophagy and the formation of autophagosomes. Sanchez
et al. [95] found that AMPK and ULK1 are interacting
partners during periods of nutrient abundance, with nutri-
ent stress causing their dissociation and an increase in
ULK1 activity (through AMPK-dependent phosphoryl-
ation), thereby aiding in autophagosome biogenesis.
Surprisingly, the aforementioned studies generally
found that the nutrient-responsive kinase, mammalian
target of rapamycin (mTOR), contributed little to the
induction of autophagy in skeletal muscle during starva-
tion. Zhao et al. [122] found that inhibition of mTOR
complex 1 (mTORC1) in C2C12 myotubes by rapamycin
only resulted in a slight increase in autophagy, while in-
hibition of the upstream kinase, Akt, via API-2, induced
an autophagic response that was fivefold greater than
that with rapamycin treatment. Similarly, Mammucari
and colleagues [68] found that rapamycin inhibition and
knockdown of mTOR had little effect on the induction
of lysosomal proteolysis. This same study also indicated
that the RNAi-mediated knockdown of the rapamycin-
insensitive mTOR complex (mTORC2) did induce
FoxO3 translocation into the nucleus. In contrast to
these findings, a recent study indicated that constitutive
activation of mTORC1 in the skeletal muscle of tuber-
ous sclerosis 1 (TSC1)-deficient mice inhibited autoph-
agy despite AMPK and FoxO3 activation [12]. In these
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phosphorylate ULK1 and thereby prevent the AMPK-
dependent phosphorylation of ULK1 that is necessary
for autophagosome formation [49]. Indeed, rapamycin
administration or institution of a ULK1 mutant that was
insusceptible to mTORC1 phosphorylation was suffi-
cient to restore autophagic flux. While this study does
not discount the importance of AMPK/FoxO3 signaling,
it does indicate that inhibition of mTORC1 may be
necessary for efficient autophagy induction. Interestingly,
these two signaling pathways have been linked, with
AMPK being capable of phosphorylating mTORC1 and
disrupting any interaction with ULK1 [95]. Thus, the
discrepancies in the aforementioned studies may suggest
that an initial decrease in ATP to AMP ratio during
nutrient deprivation may activate AMPK, which will
subsequently initiate FoxO3 signaling and, concurrently,
inhibit mTORC1 to allow ULK1 function and autophagy
to be initiated.
An additional aspect of nutrient deprivation that dir-
ectly affects mTOR and thereby autophagic signaling is
the lack of intake of essential amino acids (e.g., leucine).
This deficiency prevents amino acid-induced mTORC1
translocation to lysosomal membranes where mTORC1
would be activated through an interaction with Rag
GTPases and the ragulator protein complex [94]. Given
that growth factor and amino acid-dependent signaling
converge at the same point (i.e., mTOR), it is likely that
these two signaling pathways act in concert during nutri-
ent deprivation to activate autophagy and recycle essen-
tial building blocks.
Autophagy and metabolism
The link between autophagy and metabolism has been
well established based on its function in recycling dam-
aged proteins and organelles during energy stress. How-
ever, recently, autophagy has been suggested to play a
role in carbohydrate and lipid metabolism. In the latter
case, evidence has emerged that autophagic activity is
inversely correlated with intramyocellular triglyceride
levels in morbidly obese patients following bariatric sur-
gery [55]. These researchers also found that L6 rat myo-
cytes cultured with free fatty acids showed increased
lipid accumulation and cell death when autophagy was
inhibited and decreased lipid accumulation when au-
tophagy was activated. These results clearly imply a role
for autophagy in lipid metabolism; however, further
experiments will be needed to elucidate its exact role.
Skeletal muscle carbohydrate metabolism also appears
to be affected by autophagic flux, with the strongest evi-
dence emerging from the study of various muscle path-
ologies. For instance, in patients with Danon disease,
glycogen granules accumulate in autophagosomes that
are unable to fuse with lysosomes for proper clearance,which leads to muscle weakness [82]. Interestingly, pa-
tients with Pompe disease exhibit a defect in glycogen
breakdown within lysosomes, and muscle-specific inhib-
ition of autophagic transport of glycogen to lysosomes
confers some therapeutic benefits [33, 90]. Autophagy
may also be linked to glucose homeostasis. Mice defi-
cient in exercise-induced autophagy (i.e., inhibited re-
lease of beclin-1 from the BCL2-beclin-1 complex) also
show decreased insulin sensitivity and impaired redistri-
bution of glucose transporter 4 (GLUT4) in skeletal
muscle cells in response to acute exercise [41]. More-
over, this study demonstrated that impaired exercise-
induced autophagy negated the exercise-mediated bene-
fits to glucose tolerance in obese mice. In direct oppos-
ition to this study, muscle-specific knockout of Atg7
(suppressing autophagy) led to increased lipid oxidation
and decreased high-fat diet-induced insulin resistance
[51]. While in not identical studies, the discrepancies do
indicate the need for further investigation regarding the
role (if any) of autophagy in insulin sensitivity and glu-
cose homeostasis. These studies aside, it appears likely
that autophagy plays an important role in lipid and
glycogen metabolism within skeletal muscle cells; how-
ever, the underlying mechanisms remain unclear.
Autophagy dysfunction and disease
The necessity for proper autophagic flux in maintaining
skeletal muscle functioning is most evident when one
considers the pathologies that accompany a dysfunc-
tional autophagic process. The aforementioned Danon
disease is a prime example of myopathy caused by dis-
turbed autophagic flux, with impaired autophagosome/
lysosome fusion leading to muscle weakness and various
extra-muscular effects. Similarly, there are a variety of
other related diseases that likely develop, at least in part,
due to defects in autophagosome/lysosome fusion. These
include Vici syndrome [17], X-linked myopathy with ex-
cessive autophagy, adult-onset vacuolar myopathy with
multiorgan involvement, and infantile vacuolar autopha-
gic myopathy [81]. Moreover, muscle disorders can arise
from the defects in the autophagic clearance of disease-
causing molecules. For instance, in sporadic inclusion
body myositis, one of the principle mechanisms for its
initiation is the accumulation of amyloid precursor pro-
tein and its fragment, β-amyloid in muscle cells [5].
These two proteins associate with LC3 in cultured
muscle cells and biopsied degenerating muscle fibers,
which suggests that they may be cleared through
autophagy [65]. Similarly, limb girdle muscular dys-
trophy type 2B and Miyoshi myopathy arise due to the
aggregation of mutant dysferlin (typically a sarcolemmal
protein) in the endoplasmic reticulum. Activation of the
stress-induced autophagic pathway increases mutant
dysferlin degradation, while a blockade in autophagy
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tion [32]. Accumulation of mutant filamin C, an actin-
binding protein that functions at the Z-disk, also triggers
protein aggregation and the development of myofibrillar
myopathy. This accumulation is thought to be due in
part to a disruption in chaperone-assisted selective
autophagy (CASA) [53]. Additionally, skeletal muscles of
one of the more detrimental myopathies, Duchenne
muscular dystrophy, were recently found to display im-
paired autophagy. This was evidenced by decreased LC3
lipidation, the accumulation of damaged organelles, and
decreased expression of autophagy-related genes [20].
Lastly, disrupted autophagy is thought to play an
important role in the progression of myopathies derived
from mutated collagen VI genes, such as Ullrich con-
genital muscular dystrophy and Bethlem disease
(reviewed in [97]). These genes encode for a key skeletal
muscle extracellular matrix (ECM) protein [56], and
studies of skeletal muscle Col6a1−/− mice and humans
have indicated that this defect leads to the formation of
abnormal mitochondria and SR, as well as the initiation
of apoptosis [4, 43]. Subsequent experiments revealed
that these aberrant organelles were the result of a mal-
function in the autophagic process, specifically impair-
ment in autophagosome formation [38]. Indeed,
nutritional or pharmacological reactivation of autophagy
attenuated the dystrophic phenotype in Col6a1-/- mice.
Taken together, these myopathies further illustrate the
importance of skeletal muscle autophagy in maintaining
normal muscle function and identifying the constellation
of relevant autophagy/vacuolar proteases that manage
this process will be a high priority.
Caspase-mediated proteolysis
Caspases (cysteine-aspartic proteases) are a family of
proteolytic enzymes that are most commonly known for
their role in initiating apoptosis. Caspases are typically
classified as initiator caspases (caspase-2, caspase-8,
caspase-9, caspase-10) or effector caspases (caspase-3,
caspase-6, caspase-7), with the former being responsible
for activating the effector caspases. The role of caspases
in apoptosis and the association of these proteases with
various forms of muscle atrophy have reinforced the
negative stereotype of this protein family, as conduits of
cell destruction [26]. Despite the prevailing death-centric
view, caspase-mediated signaling events have been
linked to a diverse array of vital cell tasks, which are in-
dependent of inducing apoptosis [24].
Caspases and satellite cell commitment
Satellite cell commitment to the muscle cell lineage is an
essential step in muscle growth and regeneration. Cas-
pase activity appears to be intimately involved in this
process as recent studies have indicated that caspase 3activity directly limits satellite cell self renewal, by cleav-
ing and inactivating the paired box transcription factor
Pax7 [23, 83]. Pax7 is essential to maintain the satellite
cell niche and must be removed for satellite cells to
acquire differentiation competence [84]. Given that Pax7
is subject to both caspase and ubiquitin targeted degrad-
ation, a reasonable conjecture may be that these pro-
cesses work in tandem to ensure the acquisition of a
differentiation competent state. One could envision the
initial caspase-dependent cleavage of Pax7, followed by
ubiquitination and removal of Pax7 fragments. How and
whether these proteolytic systems engage in crosstalk
will require further experimentation.
Caspases and skeletal myoblast differentiation
Skeletal myoblast differentiation and the early steps in
apoptosis possess a remarkable number of similarities.
For instance, actin fiber disassembly/reorganization and
phospholipid reorientation are features of both apoptosis
[15] and differentiation [34, 88, 117]. Moreover, these
seemingly conflicting cell fates both require increased
activity of select matrix metalloproteinases [69, 120].
These similarities spurred a controversial hypothesis that
suggested muscle cell differentiation and apoptosis may
utilize overlapping signaling cascades, a supposition that
was initially addressed in 2002. Here, Fernando et al.
[29] demonstrated that transient caspase-3 activity is
required for myoblast differentiation and that this non-
death activity is mediated in part through the cleavage
activation of the mammalian sterile 20-like kinase-1,
MST1. Subsequent studies have established that the key
elements of the intrinsic mediated cell death pathway
are fully conserved to engage caspase 3 during myoblast
differentiation [37, 77]. Once activated, caspase 3 targets
multiple substrates to engage the differentiation program
(Fig. 4). These substrates include promyogenic kinases
such as MST1, HIPK2, NEK5 [19, 29, 101], the posttran-
scriptional regulatory protein ELAV-like protein (HuR)
[6], and caspase-activated DNase (CAD), where the lat-
ter is activated by cleaving and removing its nascent in-
hibitor inhibitor of caspase-activated DNase (ICAD)
[57]. CAD promotes myoblast differentiation by inflict-
ing transient DNA strand breaks at the promoters of
critical regulatory factors such as the cell cycle inhibitor
p21, an event that leads to p21 induction [2, 57]. Inter-
estingly, CAD-sensitive strand breaks are detectable
throughout differentiating myonuclei, suggesting that
the DNase may engage a genome wide reprogramming
event to alter the expression of a large number of gene
targets. It is important to note that these DNA strand
breaks need to be resolved quickly for proper muscle cell
differentiation, and recent evidence has indicated that
the base excision repair protein, XRCC1, is a key player
in mending CAD-dependent breakage events [2].
Fig. 4 The role of caspases in skeletal myoblast differentiation. Caspase 3 has a multifaceted role in regulating myogenesis. It is responsible for
the proteolytic cleavage of the transcription factor Pax7, which maintains satellite cells in their stem cell niche and prevents myoblast differentiation.
Moreover, caspase 3 cleaves the promyogenic kinases MST1, HIPK2, and NEK5 to promote myogenesis. The posttranscriptional regulator, HuR, is also
cleaved by caspase 3 and is necessary for muscle fiber formation. Additionally, preliminary evidence (unpublished) suggests that the myogenic
differentiation program appears to rely on the caspase-mediated cleavage of chromatin remodeling proteins to increase DNA accessibility for
CAD (activated by caspase 3 cleavage of ICAD), which produces DNA strand breaks that are critical to regulating myogenic gene expression.
For instance, CAD cleavage of the p21 promoter stimulates p21 expression, which is essential for cell cycle arrest and terminal differentiation.
The CAD-derived DNA strand breaks require rapid resolution, which is mediated by the base excision repair protein XRCC1. This mending of
DNA strand breaks is necessary to stabilize the genome and ensure the fidelity of the myogenic differentiation program
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caspase 3 regulates other key features of myogenesis. For
instance, phosphatidylserine receptor-mediated caspase 3
activation has been reported to enhance myoblast fusion
to existing myofibers. The relevant caspase substrates have
not been characterized in this process, yet the protease
activity appears to be a critical step in effecting muscle
maturation and regeneration via cell fusion [42].
These observations confirm that caspase 3 acts at mul-
tiple points to secure the differentiation program, yet the
mechanism that spurs caspase activity at these specific
temporal junctures remains unknown. Satellite cell acti-
vation has been reported to trigger engagement of the
extrinsic mediated cell death pathway such as the Fas-
associated protein with death domain (FADD) receptor
[14], yet the requisite initiator caspase for this pathway,
caspase 8, does not appear to be appreciably activated at
this stage [37]. Given the central role of caspase 3 signal-
ing in the differentiation process, there is a significant
need to identify (1) the pathways that engage the activa-
tion of this protease, (2) the full range of substrates that
facilitate its capacity to induce differentiation, and (3)the mechanisms that restrain protease activity and direct
it to a non-death cell function.
Caspases and skeletal muscle adaptation
The central role of caspase 3 in directing myoblast differ-
entiation suggests that this protease and its cognate sig-
naling pathways may retain non-death functions within
fully formed myofibers. Notably, Wang et al. [113] have
reported that caspase 3 targets and cleaves proteins that
lead to acetylcholine receptor dispersal in postsynaptic
membranes, a key step in the development of the neuro-
muscular junction. Skeletal muscle fibers express the rep-
ertoire of caspase regulatory proteins, and caspase 3 has
been linked to a wide array of remodeling activities in
various cell lineages, including postsynaptic remodeling in
neurons and cardiomyocyte hypertrophy [24, 86]. The link
between caspase 3 and cardiomyocyte hypertrophy is of
particular interest as this form of cell growth is an adap-
tive stress response. As cardiac and skeletal muscle cells
share a remarkable overlap in regulatory gene expression,
sarcomere assembly/content etc., it is not unreasonable to
suggest that caspase 3 activity may also manage the
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proteolytic targeting steps.
How caspase 3 activity translates to a beneficial stress
adaptation in skeletal muscle fibers is currently unknown.
One probable mechanism may involve direct communica-
tion between caspase 3 and other proteostatic control
mechanisms within the muscle fiber (i.e., caspase signaling
may serve to control both proteasome and autophagy-
related signaling during muscle adaptation). To date, over
500 physiologic substrates have been identified for caspase
3/7, as such the ability of an effector caspase to target and
integrate regulatory control over disparate proteolytic
mechanisms is an entirely probable event. In Drosophila
oogenesis, the effector caspase equivalent, death caspase-1
(DCP-1), has been shown to promote autophagy flux by
cleaving and inhibiting the key autophagy suppressing
protein SesB [22]. Whereas autophagy has been generally
associated with muscle atrophy/wasting, a number of
studies have shown that resistance trained skeletal muscle
is associated with enhanced autophagic flux [62, 114]. The
observations in Drosophila have established the existence
of a caspase-directed autophagy signal, whether skeletal
muscle utilizes a similar beneficial regulatory cascade will
require further investigation. Simultaneous caspase activa-
tion and proteosome signaling in skeletal muscle are
understood to have generally negative outcomes, associ-
ated with wasting and atrophy in a variety of disease set-
tings [26, 71, 102]. Nevertheless, caspase 3 has been
demonstrated to target and cleave subunits of the 19S
proteasome (Rpt2 and Rpt6), leading to an obligatory
increase in proteasome activity during myoblast differenti-
ation [112]. Mutation of the respective caspase 3 cleavage
sites in Rpt2 and Rpt6 resulted in failure to up-regulate
the 19S proteasome, with a profound block in the differ-
entiation program. Clearly, the uncontrolled engagement
of this signaling interaction would have dire consequences
for myofiber viability, yet one can easily envision that a
transient activation of these proteases may act to remodel
the ultrastructure of the myofiber in response to physio-
logic demands.
What remains unknown are the biochemical controls
that allow for the activation of effector caspases, while
avoiding induction of cell death/apoptosis. As noted
above, caspase-mediated cell differentiation is a broadly
conserved mechanism that spans all cell lineages and is
extant from worms to humans [24]. The key distinction
between death and non-death caspase function is the
duration of the signaling cascade, where cell death is
characterized by sustained caspase 3/7 activity, non-
death responses by a transient activity pattern [23, 37,
77]. A probable loci of caspase control may reside with
the inhibitor of apoptosis (IAPs), a class of RING Finger
domain proteins that target and inhibit caspase activity
by both structural blockade and through self directedubiquitination of the IAP/caspase complex [21, 63, 107].
One IAP, X-linked inhibitor of apoptosis (XIAP), has
been investigated for its capacity to modify caspase
activity during myoblast differentiation, with studies sup-
porting a role for XIAP in this regard [77, 103] and a
study that concludes otherwise [9]. The additional IAPs
such as cIAP1 and cIAP2 may provide similar levels of
control yet they have not been investigated in this con-
text. Finally, it is relevant to note, that while protein
interactions with the effector caspases may direct the
activation of these proteases for non-death outcomes,
the ultimate arbiter of control may originate with the
initiation signal per se. Activation of intrinsic and/or
extrinsic cell death signal cascades during non-apoptotic
cell adaptation(s) are themselves uniformly transient
[30, 115], suggesting that external physiologic inputs
may be the deciding factor in managing effector
caspase-mediated outcomes in any tissue, including
skeletal muscle.
Conclusions
In addition to its role in simply maintaining proteostasis,
proteolysis is an essential part of the production of new
skeletal muscle fibers and adapting muscle fibers to cel-
lular stress. Current research clearly indicates a critical
role of protein degradation in the regulation of the myo-
genic differentiation program, ensuring timely protein
expression for myoblast differentiation while also medi-
ating myoblast fusion and myotube formation. The ma-
ture muscle fiber then relies on appropriate protein
degradation to rid the cell of damaged proteins from the
mechanical and oxidative stress that accompanies the
force-bearing/force-generating function of skeletal
muscle. Additionally, during nutrient deprivation the or-
ganism depends on skeletal muscle proteolysis to main-
tain whole-body energy homeostasis. Not surprisingly,
defects within these proteolytic systems often result in
the development of myopathic conditions. Thus, future
work in this field should focus on delineating the mech-
anistic details of protease function in healthy skeletal
muscle. In our opinion, this information is essential, as
indiscriminate targeting of proteolytic pathways as a
means to treat muscle atrophy may engender more harm
than benefit.
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